Equity
€220,296 ▲ 144%
Equity rose in 2025 from €90,263 to €220,296.
NOVUP
Lifetime
19 annual accounts with figures on one time axis, 24 filings since 2002peak €186,905 (2025)
€186,905▲ 306%
lowest -€31,142 (2019)
€130,033▲ €138,812
peak €243,003 (2013)
€220,296▲ 144%
€532,943▲ 2.0%
peak 0.1 FTE (2018)
-not published
Board4 names since 2017
2 directors and 1 other
Documentsfilings and deeds
05-02-20265 days late
2025micro format
Gross margin from €46,022 to €186,905Back to profit: €130,033Equity from €90,263 to €220,296Cash from €29,264 to €167,788
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,614 companies had the same profile as NOVUP has now. Each dot stands for 7 companies, two years later.
97.3%
were still trading
2.0%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,614 companies, not a prediction for NOVUP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0472546683
Purpose change
“Les expertises et traitements à but non thérapeutique” (deed in French) · General meeting of 05-12-2024 · Gazette deed
2 directors appointed, 2 resignations
Appointments: (director) and (director) · Resignations: and · Legal-form conversion: from public limited company to private limited company · General meeting of 14-12-2023 · Gazette deed
Reappointments: (managing director) and (managing director)
General meeting of 26-05-2017 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| NOVUP Uccle | €753,239 | €186,905 | 29.2% | - |
| FEMENINA Woluwe-Saint-Pierre | €684,629 | €197,968 | 100.0% | - |
| Dokterskabinet Patricia VERBEURE Bruges | €733,012 | €189,210 | 99.0% | - |
| DOKTER W. VERHAEGHE Oudenburg | €741,491 | €189,367 | 92.4% | - |
| OPHTAPHIL Philippeville | €798,139 | €193,975 | 84.7% | - |
| DOKTER LUC FIDLERS Hooglede | €761,832 | €201,738 | 82.1% | - |
| DOKTER VAN DER DONCK Grobbendonk | €709,796 | €176,840 | 84.7% | - |
These companies have the same main activity as NOVUP: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €685,000 and €798,000, founded between 1998 and 2002.
Official details
Source: KBO- Status
- Active since 08-08-2000Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.096.904.5271640 Sint-Genesius-Rode, since 23-01-2001
- Financial year end
- 30 June
- Peppol
- Reachable since 05-04-2025
Annual accounts to 30-06-2025
- ≈ €350,000estimated
- €753,239▲ 22.9%
- ≈ 0 FTEestimated
- Filing
- Filed on 05-02-2026
Insights on NOVUP
NOVUP files the micro format. That format states no turnover. The gross margin rose from €85,102 in 2007 to €186,905 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about NOVUP
- What is the company number of NOVUP?
- The company number of NOVUP is 0472.546.683. The VAT number is the same number with BE in front: BE 0472.546.683.
- Where is NOVUP based?
- The registered office is at Prins de Lignelaan 116, 1180 Uccle.Company details
- What does NOVUP do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of NOVUP?
- NOVUP is a private limited company (BV).
- When was NOVUP founded?
- NOVUP was founded on 08-08-2000.
- Is NOVUP still active?
- Yes, NOVUP is an active enterprise in the KBO register.
- How many employees does NOVUP have?
- NOVUP had an average of 1 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
- What is the turnover of NOVUP?
- The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €186,905 and 40 comparable companies (NACE 86220). It probably lies between €290,000 and €460,000.
- Is NOVUP profitable?
- In financial year 2025, NOVUP made a profit of €130,033.
- Where can I find the annual accounts of NOVUP?
- NOVUP filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of NOVUP due?
- NOVUP must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.